Skip to main content
. 2021 Aug 31;38(10):5221–5237. doi: 10.1007/s12325-021-01891-8

Fig. 4.

Fig. 4

Trend over time for monthly total healthcare costs and medical costs (2018 US dollars) before and after initiation of suvorexant for a prevalent insomnia cohort and b incident insomnia cohort. US United States